1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Interferons – Secondary Research
1.3.2. Others – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Tires – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope
2. Executive Summary
2.1. Market Snapshot: Global Multiple Sclerosis Treatment Market
2.2. Global Multiple Sclerosis Treatment Market, By Drug Class
2.3. Global Multiple Sclerosis Treatment Market, By Route of Administration
2.4. Global Multiple Sclerosis Treatment Market, By Distribution Channel
2.5. Global Multiple Sclerosis Treatment Market, By Region
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Multiple Sclerosis Treatment Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Drug Class
3.5.2. Route of Administration
3.5.3. Distribution Channel
3.5.4. Geography
4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Drug Class Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend
5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Tires Shops
6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa
7. Global Multiple Sclerosis Treatment Market, By Drug Class
7.1. Global Multiple Sclerosis Treatment Market Overview, by Drug Class
7.1.1. Global Multiple Sclerosis Treatment Market Revenue Share, By Drug Class, 2022 Vs 2030 (in %)
7.2. Immunomodulators
7.2.1. Global Multiple Sclerosis Treatment Market, By Region, 2017-2030 (US$ Bn)
7.3. Immunosuppressants
7.3.1. Global Multiple Sclerosis Treatment Market, By Region, 2017-2030 (US$ Bn)
7.4. Interferons
7.4.1. Global Multiple Sclerosis Treatment Market, By Region, 2017-2030 (US$ Bn)
7.5. Others
7.5.1. Global Multiple Sclerosis Treatment Market, By Region, 2017-2030 (US$ Bn)
8. Global Multiple Sclerosis Treatment Market, By Route of Administration
8.1. Global Multiple Sclerosis Treatment Market Overview, by Route of Administration
8.1.1. Global Multiple Sclerosis Treatment Market, By Route of Administration, 2022 vs 2030 (in %)
8.2. Oral
8.2.1. Global Multiple Sclerosis Treatment Market, By Region, 2017-2030 (US$ Bn)
8.3. Injectables
8.3.1. Global Multiple Sclerosis Treatment Market, By Region, 2017-2030 (US$ Bn)
8.4. Infusions
8.4.1. Global Multiple Sclerosis Treatment Market, By Region, 2017-2030 (US$ Bn)
9. Global Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2030 (US$ Bn)
9.1. Global Multiple Sclerosis Treatment Market Overview, by Distribution Channel
9.1.1. Global Multiple Sclerosis Treatment Market, By Distribution Channel, 2022 vs 2030 (in%)
9.2. Hospital Pharmacy
9.2.1. Global Multiple Sclerosis Treatment Market, By Region, 2017-2030 (US$ Bn)
9.3. Retail Pharmacy
9.3.1. Global Multiple Sclerosis Treatment Market, By Region, 2017-2030 (US$ Bn)
9.4. Online Stores
9.4.1. Global Multiple Sclerosis Treatment Market, By Region, 2017-2030 (US$ Bn)
10. Global Multiple Sclerosis Treatment Market, By Region
10.1. Global Multiple Sclerosis Treatment Market Overview, by Region
10.1.1. Global Multiple Sclerosis Treatment Market, By Region, 2022 vs 2030 (in%)
10.2. Drug Class
10.2.1. Global Multiple Sclerosis Treatment Market, By Drug Class, 2017-2030 (US$ Bn)
10.3. Route of Administration
10.3.1. Global Multiple Sclerosis Treatment Market, By Route of Administration, 2017-2030 (US$ Bn)
10.4. Distribution Channel
10.4.1. Global Multiple Sclerosis Treatment Market, By Distribution Channel, 2017-2030 (US$ Bn)
11. North America Multiple Sclerosis Treatment Market Analysis
11.1. North America Multiple Sclerosis Treatment Market, by Drug Class, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. North America Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2030(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. North America Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2030(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. North America Multiple Sclerosis Treatment Market, by Country, 2017-2030 (US$ Bn)
11.4.1. North America Multiple Sclerosis Treatment Market, by Country, 2022 Vs 2030 (in%)
11.4.2. U.S.
11.4.2.1. U.S. Multiple Sclerosis Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.2.2. U.S. Multiple Sclerosis Treatment, By Drug Class, 2017-2030 (US$ Bn)
11.4.2.3. U.S. Multiple Sclerosis Treatment, By Route of Administration, 2017-2030 (US$ Bn)
11.4.2.4. U.S. Multiple Sclerosis Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
11.4.3. Canada
11.4.3.1. Canada Multiple Sclerosis Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.3.2. Canada Multiple Sclerosis Treatment, By Drug Class, 2017-2030 (US$ Bn)
11.4.3.3. Canada Multiple Sclerosis Treatment, By Route of Administration, 2017-2030 (US$ Bn)
11.4.3.4. Canada Multiple Sclerosis Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
11.4.4. Mexico
11.4.4.1. Mexico Multiple Sclerosis Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.4.2. Mexico Multiple Sclerosis Treatment, By Drug Class, 2017-2030 (US$ Bn)
11.4.4.3. Mexico Multiple Sclerosis Treatment, By Route of Administration, 2017-2030 (US$ Bn)
11.4.4.4. Mexico Multiple Sclerosis Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
12. Europe Multiple Sclerosis Treatment Market Analysis
12.1. Europe Multiple Sclerosis Treatment Market, by Drug Class, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Europe Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Europe Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2030(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Europe Multiple Sclerosis Treatment Market, by Country, 2017-2030 (US$ Bn)
12.4.1. Europe Multiple Sclerosis Treatment Market, by Country, 2022 Vs 2030 (in%)
12.4.2. Germany
12.4.2.1. Germany Multiple Sclerosis Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.2.2. Germany Multiple Sclerosis Treatment, By Drug Class, 2017-2030 (US$ Bn)
12.4.2.3. Germany Multiple Sclerosis Treatment, By Route of Administration, 2017-2030 (US$ Bn)
12.4.2.4. Germany Multiple Sclerosis Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
12.4.3. France
12.4.3.1. France Multiple Sclerosis Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.3.2. France Multiple Sclerosis Treatment, By Drug Class, 2017-2030 (US$ Bn)
12.4.3.3. France Multiple Sclerosis Treatment, By Route of Administration, 2017-2030 (US$ Bn)
12.4.3.4. France Multiple Sclerosis Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
12.4.4. UK
12.4.4.1. UK Multiple Sclerosis Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.4.2. UK Multiple Sclerosis Treatment, By Drug Class, 2017-2030 (US$ Bn)
12.4.4.3. UK Multiple Sclerosis Treatment, By Route of Administration, 2017-2030 (US$ Bn)
12.4.4.4. UK Multiple Sclerosis Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
12.4.5. Italy
12.4.5.1. Italy Multiple Sclerosis Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.5.2. Italy Multiple Sclerosis Treatment, By Drug Class, 2017-2030 (US$ Bn)
12.4.5.3. Italy Multiple Sclerosis Treatment, By Route of Administration, 2017-2030 (US$ Bn)
12.4.5.4. Italy Multiple Sclerosis Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
12.4.6. Spain
12.4.6.1. Spain Multiple Sclerosis Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.6.2. Spain Multiple Sclerosis Treatment, By Drug Class, 2017-2030 (US$ Bn)
12.4.6.3. Spain Multiple Sclerosis Treatment, By Route of Administration, 2017-2030 (US$ Bn)
12.4.6.4. Spain Multiple Sclerosis Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
12.4.7. Rest of Europe
12.4.7.1. Rest of Europe Multiple Sclerosis Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.7.2. Rest of Europe Multiple Sclerosis Treatment, By Drug Class, 2017-2030 (US$ Bn)
12.4.7.3. Rest of Europe Multiple Sclerosis Treatment, By Route of Administration, 2017-2030 (US$ Bn)
12.4.7.4. Rest of Europe Multiple Sclerosis Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
13. Asia Pacific Multiple Sclerosis Treatment Market Analysis
13.1. Asia Pacific Multiple Sclerosis Treatment Market, by Drug Class, 2017-2030(US$ Bn)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. Asia Pacific Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2030(US$ Bn)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. Asia Pacific Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2030(US$ Bn)
13.3.1. Overview
13.3.2. SRC Analysis
13.4. Asia Pacific Multiple Sclerosis Treatment Market, by Country, 2017-2030 (US$ Bn)
13.4.1. Asia Pacific Multiple Sclerosis Treatment Market, by Country, 2022 Vs 2030 (in%)
13.4.2. China
13.4.2.1. China Multiple Sclerosis Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.2.2. China Multiple Sclerosis Treatment, By Drug Class, 2017-2030 (US$ Bn)
13.4.2.3. China Multiple Sclerosis Treatment, By Route of Administration, 2017-2030 (US$ Bn)
13.4.2.4. China Multiple Sclerosis Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
13.4.3. Japan
13.4.3.1. Japan Multiple Sclerosis Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.3.2. Japan Multiple Sclerosis Treatment, By Drug Class, 2017-2030 (US$ Bn)
13.4.3.3. Japan Multiple Sclerosis Treatment, By Route of Administration, 2017-2030 (US$ Bn)
13.4.3.4. Japan Multiple Sclerosis Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
13.4.4. India
13.4.4.1. India Multiple Sclerosis Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.4.2. India Multiple Sclerosis Treatment, By Drug Class, 2017-2030 (US$ Bn)
13.4.4.3. India Multiple Sclerosis Treatment, By Route of Administration, 2017-2030 (US$ Bn)
13.4.4.4. India Multiple Sclerosis Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
13.4.5. South Korea
13.4.5.1. South Korea Multiple Sclerosis Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.5.2. South Korea Multiple Sclerosis Treatment, By Drug Class, 2017-2030 (US$ Bn)
13.4.5.3. South Korea Multiple Sclerosis Treatment, By Route of Administration, 2017-2030 (US$ Bn)
13.4.5.4. South Korea Multiple Sclerosis Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
13.4.6. South-East Asia
13.4.6.1. South-East Asia Multiple Sclerosis Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.6.2. South-East Asia Multiple Sclerosis Treatment, By Drug Class, 2017-2030 (US$ Bn)
13.4.6.3. South-East Asia Multiple Sclerosis Treatment, By Route of Administration, 2017-2030 (US$ Bn)
13.4.6.4. South-East Asia Multiple Sclerosis Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
13.4.7. Rest of Asia Pacific
13.4.7.1. Rest of Asia Pacific Multiple Sclerosis Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.7.2. Rest of Asia Pacific Multiple Sclerosis Treatment, By Drug Class, 2017-2030 (US$ Bn)
13.4.7.3. Rest of Asia Pacific Multiple Sclerosis Treatment, By Route of Administration, 2017-2030 (US$ Bn)
13.4.7.4. Rest of Asia Pacific Multiple Sclerosis Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
14. Latin America Multiple Sclerosis Treatment Market Analysis
14.1. Latin America Multiple Sclerosis Treatment Market, by Drug Class, 2017-2030(US$ Bn)
14.1.1. Overview
14.1.2. SRC Analysis
14.2. Latin America Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2030(US$ Bn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Latin America Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2030(US$ Bn)
14.3.1. Overview
14.3.2. SRC Analysis
14.4. Latin America Multiple Sclerosis Treatment Market, by Country, 2017-2030 (US$ Bn)
14.4.1. Latin America Multiple Sclerosis Treatment Market, by Country, 2022 Vs 2030 (in%)
14.4.2. Brazil
14.4.2.1. Brazil Multiple Sclerosis Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.4.2.2. Brazil Multiple Sclerosis Treatment, By Drug Class, 2017-2030 (US$ Bn)
14.4.2.3. Brazil Multiple Sclerosis Treatment, By Route of Administration, 2017-2030 (US$ Bn)
14.4.2.4. Brazil Multiple Sclerosis Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
14.4.3. Argentina
14.4.3.1. Argentina Multiple Sclerosis Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.4.3.2. Argentina Multiple Sclerosis Treatment, By Drug Class, 2017-2030 (US$ Bn)
14.4.3.3. Argentina Multiple Sclerosis Treatment, By Route of Administration, 2017-2030 (US$ Bn)
14.4.3.4. Argentina Multiple Sclerosis Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
14.4.4. Rest of Latin America
14.4.4.1. Rest of Latin America Multiple Sclerosis Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.4.4.2. Rest of Latin America Multiple Sclerosis Treatment, By Drug Class, 2017-2030 (US$ Bn)
14.4.4.3. Rest of Latin America Multiple Sclerosis Treatment, By Route of Administration, 2017-2030 (US$ Bn)
14.4.4.4. Rest of Latin America Multiple Sclerosis Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
15. Middle East and Africa Multiple Sclerosis Treatment Market Analysis
15.1. Middle East and Africa Multiple Sclerosis Treatment Market, by Drug Class, 2017-2030(US$ Bn)
15.1.1. Overview
15.1.2. SRC Analysis
15.2. Middle East and Africa Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2030(US$ Bn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. Middle East and Africa Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2030(US$ Bn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. Middle East and Africa Multiple Sclerosis Treatment Market, by Country, 2017-2030 (US$ Bn)
15.4.1. Middle East and Africa Multiple Sclerosis Treatment Market, by Country, 2022 Vs 2030 (in%)
15.4.2. GCC Countries
15.4.2.1. GCC Countries Multiple Sclerosis Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.4.2.2. GCC Countries Multiple Sclerosis Treatment, By Drug Class, 2017-2030 (US$ Bn)
15.4.2.3. GCC Countries Multiple Sclerosis Treatment, By Route of Administration, 2017-2030 (US$ Bn)
15.4.2.4. GCC Countries Multiple Sclerosis Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
15.4.3. South Africa
15.4.3.1. South Africa Multiple Sclerosis Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.4.3.2. South Africa Multiple Sclerosis Treatment, By Drug Class, 2017-2030 (US$ Bn)
15.4.3.3. South Africa Multiple Sclerosis Treatment, By Route of Administration, 2017-2030 (US$ Bn)
15.4.3.4. South Africa Multiple Sclerosis Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
15.4.4. Rest of Middle East and Africa
15.4.4.1. Rest of Middle East and Africa Multiple Sclerosis Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.4.4.2. Rest of Middle East and Africa Multiple Sclerosis Treatment, By Drug Class, 2017-2030 (US$ Bn)
15.4.4.3. Rest of Middle East and Africa Multiple Sclerosis Treatment, By Route of Administration, 2017-2030 (US$ Bn)
15.4.4.4. Rest of Middle East and Africa Multiple Sclerosis Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
16. Company Profiles
16.1. Pfizer
16.1.1. Company Overview
16.1.2. Products/Services Portfolio
16.1.3. Geographical Presence
16.1.4. Financial Summary
16.1.4.1. Market Revenue and Net Profit (2019-2022)
16.1.4.2. Business Segment Revenue Analysis
16.1.4.3. Geographical Revenue Analysis
16.2. Bayer AG
16.3. Teva Pharmaceutical Industries Ltd
16.4. Novartis AG
16.5. Sanofi
16.6. F. Hoffmann-La Roche Ltd
16.7. Celgene Corporation
16.8. Acorda Therapeutics, Inc
16.9. Biogen, Inc
16.10. Johnson & Johnson
16.11. EMD Serono
16.12. Eisai Co., Ltd.
16.13. Apitope
16.14. AbbVie, Inc.
List of Figures
FIG. 1 Global Multiple Sclerosis Treatment Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Multiple Sclerosis Treatment Market Segmentation
FIG. 4 Global Multiple Sclerosis Treatment Market, by Drug Class, 2022 (US$ Bn)
FIG. 5 Global Multiple Sclerosis Treatment Market, by Route of Administration, 2022 (US$ Bn)
FIG. 6 Global Multiple Sclerosis Treatment Market, by Distribution Channel, 2022 (US$ Bn)
FIG. 7 Global Multiple Sclerosis Treatment Market, by Geography, 2022 (US$ Bn)
FIG. 8 Attractive Investment Proposition, by Drug Class, 2022
FIG. 9 Attractive Investment Proposition, by Route of Administration, 2022
FIG. 10 Attractive Investment Proposition, by Distribution Channel, 2022
FIG. 11 Attractive Investment Proposition, by Geography, 2022
FIG. 12 Global Market Share Analysis of Key Multiple Sclerosis Treatment Market Manufacturers, 2022
FIG. 13 Global Market Positioning of Key Multiple Sclerosis Treatment Market Manufacturers, 2022
FIG. 14 Global Multiple Sclerosis Treatment Market Value Contribution, By Drug Class, 2022 & 2030 (Value %)
FIG. 15 Global Multiple Sclerosis Treatment Market, by Immunomodulators, Value, 2017-2030 (US$ Bn)
FIG. 16 Global Multiple Sclerosis Treatment Market, by Immunosuppressants, Value, 2017-2030 (US$ Bn)
FIG. 17 Global Multiple Sclerosis Treatment Market, by Interferons, Value, 2017-2030 (US$ Bn)
FIG. 18 Global Multiple Sclerosis Treatment Market, by Others, Value, 2017-2030 (US$ Bn)
FIG. 19 Global Multiple Sclerosis Treatment Market Value Contribution, By Route of Administration, 2022 & 2030 (Value %)
FIG. 20 Global Multiple Sclerosis Treatment Market, by Oral, Value, 2017-2030 (US$ Bn)
FIG. 21 Global Multiple Sclerosis Treatment Market, by Injectables, 2017-2030 (US$ Bn)
FIG. 22 Global Multiple Sclerosis Treatment Market, by Infusions, 2017-2030 (US$ Bn)
FIG. 23 Global Multiple Sclerosis Treatment Market Value Contribution, By Distribution Channel, 2022 & 2030 (Value %)
FIG. 24 Global Multiple Sclerosis Treatment Market, by Hospital Pharmacy, Value, 2017-2030 (US$ Bn)
FIG. 25 Global Multiple Sclerosis Treatment Market, by Retail Pharmacy, 2017-2030 (US$ Bn)
FIG. 26 Global Multiple Sclerosis Treatment Market, by Online Stores, 2017-2030 (US$ Bn)
FIG. 27 North America Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
FIG. 28 U.S. Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
FIG. 29 Canada Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
FIG. 30 Europe Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
FIG. 31 Germany Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
FIG. 32 France Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
FIG. 33 U.K. Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
FIG. 34 Italy Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
FIG. 35 Spain Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
FIG. 36 Rest of Europe Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
FIG. 37 Asia Pacific Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
FIG. 38 China Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
FIG. 39 Japan Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
FIG. 40 India Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
FIG. 41 South Korea Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
FIG. 42 South-East Asia Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
FIG. 43 Rest of Asia Pacific Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
FIG. 44 Latin America Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
FIG. 45 Brazil Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
FIG. 46 Mexico Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
FIG. 47 Rest of Latin America Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
FIG. 48 Middle East & Africa Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
FIG. 49 GCC Countries Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
FIG. 50 South Africa Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
FIG. 51 Rest of Middle East and Africa Multiple Sclerosis Treatment Market, 2017-2030 (US$ Bn)
List of Tables
TABLE 1 Market Snapshot: Global Multiple Sclerosis Treatment Market
TABLE 2 Global Multiple Sclerosis Treatment Market: Market Drivers Impact Analysis
TABLE 3 Global Multiple Sclerosis Treatment Market: Market Restraints Impact Analysis
TABLE 4 Global Multiple Sclerosis Treatment Market, by Competitive Benchmarking, 2022
TABLE 5 Global Multiple Sclerosis Treatment Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Multiple Sclerosis Treatment Market, by Key Strategies Analysis, 2022
TABLE 7 Global Multiple Sclerosis Treatment Market, by Drug Class, By Region, 2017-2022 (US$ Bn)
TABLE 8 Global Multiple Sclerosis Treatment Market, by Drug Class, By Region, 2023-2030 (US$ Bn)
TABLE 9 Global Multiple Sclerosis Treatment Market, by Immunomodulators, By Region, 2017-2022 (US$ Bn)
TABLE 10 Global Multiple Sclerosis Treatment Market, by Immunomodulators, By Region, 2023-2030 (US$ Bn)
TABLE 11 Global Multiple Sclerosis Treatment Market, by Immunosuppressants, By Region, 2017-2022 (US$ Bn)
TABLE 12 Global Multiple Sclerosis Treatment Market, by Immunosuppressants, By Region, 2023-2030 (US$ Bn)
TABLE 13 Global Multiple Sclerosis Treatment Market, by Interferons, By Region, 2017-2022 (US$ Bn)
TABLE 14 Global Multiple Sclerosis Treatment Market, by Interferons, By Region, 2023-2030 (US$ Bn)
TABLE 15 Global Multiple Sclerosis Treatment Market, by Others, By Region, 2017-2022 (US$ Bn)
TABLE 16 Global Multiple Sclerosis Treatment Market, by Others, By Region, 2023-2030 (US$ Bn)
TABLE 17 Global Multiple Sclerosis Treatment Market, by Route of Administration, By Region, 2017-2022 (US$ Bn)
TABLE 18 Global Multiple Sclerosis Treatment Market, by Route of Administration, By Region, 2017-2022 (US$ Bn)
TABLE 19 Global Multiple Sclerosis Treatment Market, by Oral, By Region, 2017-2022 (US$ Bn)
TABLE 20 Global Multiple Sclerosis Treatment Market, by Oral, By Region, 2023-2030 (US$ Bn)
TABLE 21 Global Multiple Sclerosis Treatment Market, by Injectables, By Region, 2017-2022 (US$ Bn)
TABLE 22 Global Multiple Sclerosis Treatment Market, by Injectables, By Region, 2023-2030 (US$ Bn)
TABLE 23 Global Multiple Sclerosis Treatment Market, by Infusions, By Region, 2017-2022 (US$ Bn)
TABLE 24 Global Multiple Sclerosis Treatment Market, by Infusions, By Region, 2023-2030 (US$ Bn)
TABLE 25 Global Multiple Sclerosis Treatment Market, by Hospital Pharmacy, By Region, 2017-2022 (US$ Bn)
TABLE 26 Global Multiple Sclerosis Treatment Market, by Hospital Pharmacy, By Region, 2023-2030 (US$ Bn)
TABLE 27 Global Multiple Sclerosis Treatment Market, by Retail Pharmacy, By Region, 2017-2022 (US$ Bn)
TABLE 28 Global Multiple Sclerosis Treatment Market, by Retail Pharmacy, By Region, 2023-2030 (US$ Bn)
TABLE 29 Global Multiple Sclerosis Treatment Market, by Online Stores, By Region, 2017-2022 (US$ Bn)
TABLE 30 Global Multiple Sclerosis Treatment Market, by Online Stores, By Region, 2023-2030 (US$ Bn)
TABLE 31 Global Multiple Sclerosis Treatment Market, by Region, 2017-2022 (US$ Bn)
TABLE 32 Global Multiple Sclerosis Treatment Market, by Region, 2023-2030 (US$ Bn)
TABLE 33 North America Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 34 North America Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 35 North America Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 36 North America Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 37 North America Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 38 North America Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 39 North America Multiple Sclerosis Treatment Market, by Country, 2017-2022 (US$ Bn)
TABLE 40 North America Multiple Sclerosis Treatment Market, by Country, 2023-2030 (US$ Bn)
TABLE 41 United States Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 42 United States Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 43 United States Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 44 United States Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 45 United States Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 46 United States Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 47 Canada Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 48 Canada Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 49 Canada Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 50 Canada Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 51 Canada Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 52 Canada Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 53 Mexico Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 54 Mexico Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 55 Mexico Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 56 Mexico Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 57 Mexico Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 58 Mexico Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 59 Europe Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 60 Europe Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 61 Europe Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 62 Europe Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 63 Europe Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 64 Europe Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 65 Europe Multiple Sclerosis Treatment Market, by Country, 2017-2022 (US$ Bn)
TABLE 66 Europe Multiple Sclerosis Treatment Market, by Country, 2023-2030 (US$ Bn)
TABLE 67 Germany Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 68 Germany Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 69 Germany Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 70 Germany Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 71 Germany Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 72 Germany Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 73 France Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 74 France Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 75 France Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 76 France Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 77 France Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 78 France Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 79 United Kingdom Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 80 United Kingdom Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 81 United Kingdom Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 82 United Kingdom Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 83 United Kingdom Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 84 United Kingdom Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 85 Italy Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 86 Italy Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 87 Italy Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 88 Italy Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 89 Italy Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 90 Italy Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 91 Spain Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 92 Spain Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 93 Spain Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 94 Spain Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 95 Spain Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 96 Spain Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 97 Rest of Europe Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 98 Rest of Europe Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 99 Rest of Europe Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 100 Rest of Europe Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 101 Rest of Europe Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 102 Rest of Europe Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 103 Asia Pacific Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 104 Asia Pacific Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 105 Asia Pacific Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 106 Asia Pacific Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 107 Asia Pacific Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 108 Asia Pacific Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 109 China Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 110 China Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 111 China Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 112 China Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 113 China Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 114 China Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 115 Japan Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 116 Japan Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 117 Japan Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 118 Japan Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 119 Japan Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 120 Japan Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 121 India Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 122 India Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 123 India Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 124 India Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 125 India Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 126 India Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 127 South Korea Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 128 South Korea Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 129 South Korea Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 130 South Korea Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 131 South Korea Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 132 South Korea Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 133 South-East Asia Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 134 South-East Asia Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 135 South-East Asia Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 136 South-East Asia Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 137 South-East Asia Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 138 South-East Asia Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 139 Rest of Asia Pacific Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 140 Rest of Asia Pacific Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 141 Rest of Asia Pacific Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 142 Rest of Asia Pacific Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 143 Rest of Asia Pacific Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 144 Rest of Asia Pacific Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 145 Latin America Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 146 Latin America Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 147 Latin America Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 148 Latin America Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 149 Latin America Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 150 Latin America Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 151 Brazil Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 152 Brazil Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 153 Brazil Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 154 Brazil Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 155 Brazil Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 156 Brazil Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 157 Argentina Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 158 Argentina Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 159 Argentina Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 160 Argentina Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 161 Argentina Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 162 Argentina Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 163 Rest of Latin America Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 164 Rest of Latin America Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 165 Rest of Latin America Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 166 Rest of Latin America Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 167 Rest of Latin America Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 168 Rest of Latin America Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 169 Middle East and Africa Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 170 Middle East and Africa Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 171 Middle East and Africa Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 172 Middle East and Africa Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 173 Middle East and Africa Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 174 Middle East and Africa Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 175 GCC Countries Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 176 GCC Countries Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 177 GCC Countries Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 178 GCC Countries Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 179 GCC Countries Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 180 GCC Countries Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 181 South Africa Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 182 South Africa Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 183 South Africa Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 184 South Africa Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 185 South Africa Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 186 South Africa Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 187 Rest of Middle East and Africa Multiple Sclerosis Treatment Market, by Drug Class, 2017-2022 (US$ Bn)
TABLE 188 Rest of Middle East and Africa Multiple Sclerosis Treatment Market, by Drug Class, 2023-2030 (US$ Bn)
TABLE 189 Rest of Middle East and Africa Multiple Sclerosis Treatment Market, by Route of Administration, 2017-2022 (US$ Bn)
TABLE 190 Rest of Middle East and Africa Multiple Sclerosis Treatment Market, by Route of Administration, 2023-2030 (US$ Bn)
TABLE 191 Rest of Middle East and Africa Multiple Sclerosis Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 192 Rest of Middle East and Africa Multiple Sclerosis Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)